Arjun Rustagi

Arjun Rustagi

Stanford University

H-index: 23

North America-United States

About Arjun Rustagi

Arjun Rustagi, With an exceptional h-index of 23 and a recent h-index of 21 (since 2020), a distinguished researcher at Stanford University, specializes in the field of innate immunity, virology, computational analysis, respiratory infections, microbial pathogenesis.

His recent articles reflect a diverse array of research interests and contributions to the field:

An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations

Vaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of Infection Despite Transiently Enhancing Disease in SARS-CoV-2–Infected Hamsters

Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung

Administration of vaccine-boosted COVID-19 convalescent plasma to SARS-CoV-2 infected hamsters decreases virus replication in lungs and hastens resolution of the infection …

Methods enabling infection and differentiation of human distal lung organoids by sars-cov-2 and other pathogens

Organoid modeling of lung-resident immune responses to SARS-CoV-2 infection

Viral immunity: Basic mechanisms and therapeutic applications—a Keystone Symposia report

CONCISE REPORTS

Arjun Rustagi Information

University

Position

Infectious Diseases fellow

Citations(all)

3861

Citations(since 2020)

3508

Cited By

1150

hIndex(all)

23

hIndex(since 2020)

21

i10Index(all)

29

i10Index(since 2020)

25

Email

University Profile Page

Google Scholar

Arjun Rustagi Skills & Research Interests

innate immunity

virology

computational analysis

respiratory infections

microbial pathogenesis

Top articles of Arjun Rustagi

An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations

Science translational medicine

2024/3/13

Vaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of Infection Despite Transiently Enhancing Disease in SARS-CoV-2–Infected Hamsters

The Journal of Infectious Diseases

2024/1/12

Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung

Journal of Experimental Medicine

2024/4/10

Administration of vaccine-boosted COVID-19 convalescent plasma to SARS-CoV-2 infected hamsters decreases virus replication in lungs and hastens resolution of the infection …

bioRxiv

2023/8/23

Methods enabling infection and differentiation of human distal lung organoids by sars-cov-2 and other pathogens

2023/8/17

Organoid modeling of lung-resident immune responses to SARS-CoV-2 infection

Research Square

2023/5/5

Viral immunity: Basic mechanisms and therapeutic applications—a Keystone Symposia report

Annals of the New York Academy of Sciences

2023/3

Design of SARS-CoV-2 protease inhibitors with improved affinity and reduced sensitivity to mutations (preprint)

bioRxiv

2023

The B. 1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B. 1 (614G) in Syrian hamsters

PLoS pathogens

2022/2/10

Association between SARS-CoV-2 RNAemia and postacute sequelae of COVID-19

Open Forum Infectious Diseases

2022/2/1

SARS-CoV-2 RNAemia predicts clinical deterioration and extrapulmonary complications from COVID-19

Clinical Infectious Diseases

2022/1/15

SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D

Cell reports

2022/12/27

Arjun Rustagi
Arjun Rustagi

H-Index: 13

Using a 29-mRNA host response classifier to detect bacterial coinfections and predict outcomes in COVID-19 patients presenting to the emergency department

Microbiology Spectrum

2022/12/21

SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages

Science Translational Medicine

2022/9/22

The human disease gene LYSET is essential for lysosomal enzyme transport and viral infection

Science

2022/9/8

Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2

Nature medicine

2022/9

Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro

Nature communications

2022/5/19

See List of Professors in Arjun Rustagi University(Stanford University)

Co-Authors

academic-engine